HEADER TRANSFERASE 22-MAR-12 4ANX TITLE COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC COMPND 3 SUBUNIT GAMMA ISOFORM; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: CATALYTIC SUBUNIT GAMMA, RESIDUES 144-1102; COMPND 6 SYNONYM: PI3-KINASE SUBUNIT GAMMA, PI3K-GAMMA, PI3KGAMMA, PTDINS-3- COMPND 7 KINASE SUBUNIT GAMMA, PHOSPHATIDYLINOSITOL-4\,5-BISPHOSPHATE 3-KINASE COMPND 8 110 KDA CATALYTIC SUBUNIT GAMMA, PTDINS-3-KINASE SUBUNIT P110-GAMMA, COMPND 9 P110GAMMA, PHOSPHOINOSITIDE-3-KINASE CATALYTIC GAMMA POLYPEPTIDE, COMPND 10 SERINE/THREONINE PROTEIN KINASE PIK3CG, P120-PI3K; COMPND 11 EC: 2.7.1.137, 2.7.1.153, 2.7.11.1; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.G.FOSTER,J.C.LOUGHEED REVDAT 3 08-MAY-19 4ANX 1 REMARK REVDAT 2 27-JUN-12 4ANX 1 JRNL REVDAT 1 09-MAY-12 4ANX 0 JRNL AUTH J.W.LEAHY,C.A.BUHR,H.W.B.JOHNSON,B.G.KIM,T.BAIK,J.CANNOY, JRNL AUTH 2 T.P.FORSYTH,J.W.JEONG,M.S.LEE,S.MA,K.NOSON,L.WANG, JRNL AUTH 3 M.WILLIAMS,J.M.NUSS,E.BROOKS,N.HEALD,C.HOLST,C.JAEGER,S.LAM, JRNL AUTH 4 J.C.LOUGHEED,L.NGUYEN,A.PLONOWSKI,T.STOUT,P.G.FOSTER,X.WU, JRNL AUTH 5 M.F.YAKES,R.YU,W.ZHANG,P.LAMB,O.RAEBER JRNL TITL THE DISCOVERY OF A NOVEL SERIES OF POTENT AND ORALLY JRNL TITL 2 BIOAVAILABLE PHOSPHOINOSITIDE 3-KINASE GAMMA INHIBITORS JRNL REF J.MED.CHEM. V. 55 5467 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22548342 JRNL DOI 10.1021/JM300403A REMARK 2 REMARK 2 RESOLUTION. 2.73 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.73 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 26019 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1375 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.73 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1900 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.30 REMARK 3 BIN R VALUE (WORKING SET) : 0.3360 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.3860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6757 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 37 REMARK 3 SOLVENT ATOMS : 34 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01000 REMARK 3 B22 (A**2) : 0.04000 REMARK 3 B33 (A**2) : -0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.07000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.402 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.360 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 18.206 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.908 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6942 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4766 ; 0.006 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9393 ; 1.601 ; 1.965 REMARK 3 BOND ANGLES OTHERS (DEGREES): 11597 ; 0.996 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 826 ; 7.916 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 328 ;37.075 ;24.329 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1260 ;19.999 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 42 ;15.206 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1051 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7557 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1378 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1952 ; 0.260 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 5161 ; 0.217 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3376 ; 0.199 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 3774 ; 0.093 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 240 ; 0.196 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): 6 ; 0.098 ; 0.200 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 21 ; 0.137 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 27 ; 0.245 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.085 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4331 ; 0.943 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1667 ; 0.081 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6743 ; 1.277 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3059 ; 1.682 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2650 ; 2.409 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4ANX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-MAR-12. REMARK 100 THE DEPOSITION ID IS D_1290051745. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-FEB-10 REMARK 200 TEMPERATURE (KELVIN) : 155 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27406 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.730 REMARK 200 RESOLUTION RANGE LOW (A) : 32.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.73 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.77000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: IN-HOUSE PI3KG STRUCTURE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE GROWN AT 19C IN HANGING REMARK 280 DROPS USING VAPOR DIFFUSION. THE COMPLEX WAS FORMED BY REMARK 280 INCUBATING 49.5UL OF PI3KG-HIS6 (7.2 MG/ML IN 20 MM TRIS-HCL, PH REMARK 280 7.2, 50 MM (NH4)2SO4, AND 1 MM TCEP) WITH 0.5UL OF LIGAND (100 REMARK 280 MM STOCK IN 100% DMSO) FOR 30 MINUTES AT 4C. CRYSTALS OF THE REMARK 280 BINARY COMPLEX WERE OBTAINED BY MIXING 1.0UL OF THE PI3KG: REMARK 280 INHIBITOR COMPLEX WITH 1.0UL OF A RESERVOIR SOLUTION CONSISTING REMARK 280 OF 16-21% PEG 4K, 0.25 M (NH4)2SO4, AND 0.1 M TRIS-HCL, PH 7.5., REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 71.71200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.26550 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 71.71200 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 34.26550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 139 REMARK 465 LEU A 140 REMARK 465 LEU A 141 REMARK 465 GLY A 142 REMARK 465 ALA A 253 REMARK 465 LYS A 254 REMARK 465 LYS A 255 REMARK 465 LYS A 256 REMARK 465 SER A 257 REMARK 465 LEU A 258 REMARK 465 MET A 259 REMARK 465 ASP A 260 REMARK 465 ILE A 261 REMARK 465 PRO A 262 REMARK 465 GLU A 263 REMARK 465 SER A 264 REMARK 465 GLN A 265 REMARK 465 SER A 266 REMARK 465 GLU A 322 REMARK 465 TRP A 323 REMARK 465 PRO A 324 REMARK 465 LEU A 325 REMARK 465 VAL A 326 REMARK 465 ASP A 327 REMARK 465 ASP A 328 REMARK 465 CYS A 329 REMARK 465 THR A 330 REMARK 465 GLY A 331 REMARK 465 VAL A 332 REMARK 465 THR A 333 REMARK 465 GLY A 334 REMARK 465 TYR A 335 REMARK 465 HIS A 336 REMARK 465 GLU A 337 REMARK 465 GLN A 338 REMARK 465 LEU A 339 REMARK 465 THR A 340 REMARK 465 ILE A 341 REMARK 465 HIS A 342 REMARK 465 GLY A 343 REMARK 465 LYS A 344 REMARK 465 ASP A 345 REMARK 465 HIS A 346 REMARK 465 GLU A 347 REMARK 465 SER A 348 REMARK 465 VAL A 349 REMARK 465 PHE A 350 REMARK 465 THR A 351 REMARK 465 VAL A 352 REMARK 465 SER A 353 REMARK 465 LEU A 354 REMARK 465 TRP A 355 REMARK 465 ASP A 356 REMARK 465 GLY A 436 REMARK 465 LYS A 437 REMARK 465 ALA A 438 REMARK 465 PRO A 439 REMARK 465 ALA A 440 REMARK 465 LEU A 441 REMARK 465 SER A 442 REMARK 465 SER A 443 REMARK 465 LYS A 444 REMARK 465 ALA A 445 REMARK 465 SER A 446 REMARK 465 ALA A 447 REMARK 465 GLU A 448 REMARK 465 SER A 449 REMARK 465 PRO A 450 REMARK 465 SER A 451 REMARK 465 SER A 452 REMARK 465 GLU A 453 REMARK 465 SER A 454 REMARK 465 LYS A 455 REMARK 465 GLY A 456 REMARK 465 LYS A 457 REMARK 465 VAL A 458 REMARK 465 LYS A 490 REMARK 465 GLY A 491 REMARK 465 GLU A 492 REMARK 465 ASP A 493 REMARK 465 GLN A 494 REMARK 465 GLY A 495 REMARK 465 SER A 496 REMARK 465 TYR A 523 REMARK 465 CYS A 524 REMARK 465 HIS A 525 REMARK 465 PRO A 526 REMARK 465 ILE A 527 REMARK 465 ALA A 528 REMARK 465 LEU A 529 REMARK 465 PRO A 530 REMARK 465 LYS A 531 REMARK 465 HIS A 532 REMARK 465 GLN A 533 REMARK 465 PRO A 534 REMARK 465 THR A 535 REMARK 465 PRO A 536 REMARK 465 ASP A 537 REMARK 465 PRO A 538 REMARK 465 GLU A 539 REMARK 465 GLY A 540 REMARK 465 ASP A 541 REMARK 465 ARG A 542 REMARK 465 VAL A 543 REMARK 465 ASN A 969 REMARK 465 GLY A 970 REMARK 465 ASN A 971 REMARK 465 TYR A 972 REMARK 465 LYS A 973 REMARK 465 SER A 974 REMARK 465 PHE A 975 REMARK 465 LEU A 976 REMARK 465 GLY A 977 REMARK 465 ILE A 978 REMARK 465 ASN A 979 REMARK 465 LYS A 980 REMARK 465 LEU A 1088 REMARK 465 HIS A 1089 REMARK 465 LEU A 1090 REMARK 465 VAL A 1091 REMARK 465 LEU A 1092 REMARK 465 GLY A 1093 REMARK 465 ILE A 1094 REMARK 465 LYS A 1095 REMARK 465 GLN A 1096 REMARK 465 GLY A 1097 REMARK 465 GLU A 1098 REMARK 465 LYS A 1099 REMARK 465 HIS A 1100 REMARK 465 SER A 1101 REMARK 465 ALA A 1102 REMARK 465 GLU A 1103 REMARK 465 PHE A 1104 REMARK 465 GLY A 1105 REMARK 465 LEU A 1106 REMARK 465 VAL A 1107 REMARK 465 PRO A 1108 REMARK 465 ARG A 1109 REMARK 465 GLY A 1110 REMARK 465 SER A 1111 REMARK 465 GLY A 1112 REMARK 465 HIS A 1113 REMARK 465 HIS A 1114 REMARK 465 HIS A 1115 REMARK 465 HIS A 1116 REMARK 465 HIS A 1117 REMARK 465 HIS A 1118 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 143 OG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 236 OD1 ASP A 239 2.08 REMARK 500 O SER A 620 NZ LYS A 647 2.17 REMARK 500 OE2 GLU A 926 NZ LYS A 1008 2.18 REMARK 500 O LYS A 668 O HOH A 2023 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 210 N - CA - C ANGL. DEV. = 17.8 DEGREES REMARK 500 LEU A 575 CA - CB - CG ANGL. DEV. = 15.4 DEGREES REMARK 500 HIS A 967 O - C - N ANGL. DEV. = -9.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 144 -149.06 -83.19 REMARK 500 GLU A 145 62.18 -163.49 REMARK 500 GLU A 146 172.10 55.38 REMARK 500 SER A 147 -51.06 43.02 REMARK 500 PHE A 150 -72.86 -61.62 REMARK 500 ALA A 189 30.28 -87.91 REMARK 500 SER A 190 -25.32 -153.91 REMARK 500 ARG A 191 123.72 -37.70 REMARK 500 HIS A 199 49.50 37.75 REMARK 500 LEU A 211 -80.02 106.12 REMARK 500 LYS A 213 17.98 -69.74 REMARK 500 ASN A 217 69.78 175.10 REMARK 500 SER A 227 -71.37 -158.07 REMARK 500 GLN A 231 139.68 167.58 REMARK 500 PRO A 237 -35.60 -38.89 REMARK 500 PHE A 248 -54.88 -175.94 REMARK 500 ASP A 269 35.92 -93.90 REMARK 500 LEU A 281 78.82 -114.91 REMARK 500 ASN A 299 21.04 -79.81 REMARK 500 LEU A 373 -60.17 -106.37 REMARK 500 PRO A 374 100.82 -17.72 REMARK 500 ASN A 376 -142.50 -162.61 REMARK 500 ASP A 378 95.57 -12.46 REMARK 500 LEU A 379 -160.38 -104.73 REMARK 500 HIS A 389 -84.02 -122.21 REMARK 500 GLN A 391 -3.26 61.01 REMARK 500 ALA A 545 150.35 72.97 REMARK 500 ASN A 549 -81.43 -23.58 REMARK 500 ARG A 613 45.04 -89.41 REMARK 500 ARG A 614 0.93 -65.04 REMARK 500 GLN A 705 23.00 -152.83 REMARK 500 LEU A 752 36.57 -63.78 REMARK 500 SER A 753 116.54 -170.39 REMARK 500 GLU A 755 14.17 -67.94 REMARK 500 ASP A 758 148.86 -170.54 REMARK 500 ASN A 773 6.51 -65.36 REMARK 500 ASN A 776 -59.08 93.12 REMARK 500 SER A 777 -75.78 -83.76 REMARK 500 GLN A 778 -88.43 140.22 REMARK 500 SER A 782 140.64 -171.10 REMARK 500 TYR A 787 -26.84 74.80 REMARK 500 ASP A 788 73.85 -158.64 REMARK 500 ALA A 797 66.02 -104.56 REMARK 500 TYR A 867 150.93 -48.12 REMARK 500 SER A 894 -131.67 -78.75 REMARK 500 ASN A 898 -112.59 -74.13 REMARK 500 GLU A 905 -132.86 -63.33 REMARK 500 VAL A 906 -67.15 72.69 REMARK 500 ARG A 927 -36.95 -37.48 REMARK 500 THR A 957 15.20 -69.65 REMARK 500 REMARK 500 THIS ENTRY HAS 62 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU A 209 TYR A 210 -144.53 REMARK 500 TYR A 210 LEU A 211 -30.69 REMARK 500 SER A 777 GLN A 778 -45.32 REMARK 500 PHE A 965 GLY A 966 146.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 534 A 2088 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1E8Y RELATED DB: PDB REMARK 900 STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY REMARK 900 WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE REMARK 900 RELATED ID: 1E8Z RELATED DB: PDB REMARK 900 STRUCTURE DETERMINANTS OF PHOSPHOINOSITIDE 3-KINASE INHIBITION BY REMARK 900 WORTMANNIN, LY294002, QUERCETIN, MYRICETIN AND STAUROSPORINE REMARK 900 RELATED ID: 1HE8 RELATED DB: PDB REMARK 900 RAS G12V - PI 3-KINASE GAMMA COMPLEX REMARK 900 RELATED ID: 2A4Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS604850 REMARK 900 RELATED ID: 2A5U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN PI3KGAMMA COMPLEXED WITH AS605240 REMARK 900 RELATED ID: 2CHW RELATED DB: PDB REMARK 900 A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR P110 REMARK 900 ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF PHOSPHOINOSITIDE 3- REMARK 900 KINASE GAMMA WITH INHIBITOR PIK-39 REMARK 900 RELATED ID: 2CHX RELATED DB: PDB REMARK 900 A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR REMARK 900 P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF REMARK 900 PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-90 REMARK 900 RELATED ID: 2CHZ RELATED DB: PDB REMARK 900 A PHARMACOLOGICAL MAP OF THE PI3-K FAMILY DEFINES A ROLE FOR REMARK 900 P110ALPHA IN SIGNALING: THE STRUCTURE OF COMPLEX OF REMARK 900 PHOSPHOINOSITIDE 3-KINASE GAMMA WITH INHIBITOR PIK-93. REMARK 900 RELATED ID: 2V4L RELATED DB: PDB REMARK 900 COMPLEX OF HUMAN PHOSPHOINOSITIDE 3-KINASE CATALYTIC SUBUNIT GAMMA REMARK 900 (P110 GAMMA) WITH PIK-284 REMARK 900 RELATED ID: 3ZVV RELATED DB: PDB REMARK 900 FRAGMENT BOUND TO PI3KINASE GAMMA REMARK 900 RELATED ID: 3ZW3 RELATED DB: PDB REMARK 900 FRAGMENT BASED DISCOVERY OF A NOVEL AND SELECTIVE PI3 KINASE REMARK 900 INHIBITOR REMARK 900 RELATED ID: 4ANU RELATED DB: PDB REMARK 900 COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS. REMARK 900 RELATED ID: 4ANV RELATED DB: PDB REMARK 900 COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS. REMARK 900 RELATED ID: 4ANW RELATED DB: PDB REMARK 900 COMPLEXES OF PI3KGAMMA WITH ISOFORM SELECTIVE INHIBITORS. DBREF 4ANX A 144 1102 UNP P48736 PK3CG_HUMAN 144 1102 SEQADV 4ANX MET A 139 UNP P48736 EXPRESSION TAG SEQADV 4ANX LEU A 140 UNP P48736 EXPRESSION TAG SEQADV 4ANX LEU A 141 UNP P48736 EXPRESSION TAG SEQADV 4ANX GLY A 142 UNP P48736 EXPRESSION TAG SEQADV 4ANX SER A 143 UNP P48736 EXPRESSION TAG SEQADV 4ANX GLU A 1103 UNP P48736 EXPRESSION TAG SEQADV 4ANX PHE A 1104 UNP P48736 EXPRESSION TAG SEQADV 4ANX GLY A 1105 UNP P48736 EXPRESSION TAG SEQADV 4ANX LEU A 1106 UNP P48736 EXPRESSION TAG SEQADV 4ANX VAL A 1107 UNP P48736 EXPRESSION TAG SEQADV 4ANX PRO A 1108 UNP P48736 EXPRESSION TAG SEQADV 4ANX ARG A 1109 UNP P48736 EXPRESSION TAG SEQADV 4ANX GLY A 1110 UNP P48736 EXPRESSION TAG SEQADV 4ANX SER A 1111 UNP P48736 EXPRESSION TAG SEQADV 4ANX GLY A 1112 UNP P48736 EXPRESSION TAG SEQADV 4ANX HIS A 1113 UNP P48736 EXPRESSION TAG SEQADV 4ANX HIS A 1114 UNP P48736 EXPRESSION TAG SEQADV 4ANX HIS A 1115 UNP P48736 EXPRESSION TAG SEQADV 4ANX HIS A 1116 UNP P48736 EXPRESSION TAG SEQADV 4ANX HIS A 1117 UNP P48736 EXPRESSION TAG SEQADV 4ANX HIS A 1118 UNP P48736 EXPRESSION TAG SEQRES 1 A 980 MET LEU LEU GLY SER SER GLU GLU SER GLN ALA PHE GLN SEQRES 2 A 980 ARG GLN LEU THR ALA LEU ILE GLY TYR ASP VAL THR ASP SEQRES 3 A 980 VAL SER ASN VAL HIS ASP ASP GLU LEU GLU PHE THR ARG SEQRES 4 A 980 ARG GLY LEU VAL THR PRO ARG MET ALA GLU VAL ALA SER SEQRES 5 A 980 ARG ASP PRO LYS LEU TYR ALA MET HIS PRO TRP VAL THR SEQRES 6 A 980 SER LYS PRO LEU PRO GLU TYR LEU TRP LYS LYS ILE ALA SEQRES 7 A 980 ASN ASN CYS ILE PHE ILE VAL ILE HIS ARG SER THR THR SEQRES 8 A 980 SER GLN THR ILE LYS VAL SER PRO ASP ASP THR PRO GLY SEQRES 9 A 980 ALA ILE LEU GLN SER PHE PHE THR LYS MET ALA LYS LYS SEQRES 10 A 980 LYS SER LEU MET ASP ILE PRO GLU SER GLN SER GLU GLN SEQRES 11 A 980 ASP PHE VAL LEU ARG VAL CYS GLY ARG ASP GLU TYR LEU SEQRES 12 A 980 VAL GLY GLU THR PRO ILE LYS ASN PHE GLN TRP VAL ARG SEQRES 13 A 980 HIS CYS LEU LYS ASN GLY GLU GLU ILE HIS VAL VAL LEU SEQRES 14 A 980 ASP THR PRO PRO ASP PRO ALA LEU ASP GLU VAL ARG LYS SEQRES 15 A 980 GLU GLU TRP PRO LEU VAL ASP ASP CYS THR GLY VAL THR SEQRES 16 A 980 GLY TYR HIS GLU GLN LEU THR ILE HIS GLY LYS ASP HIS SEQRES 17 A 980 GLU SER VAL PHE THR VAL SER LEU TRP ASP CYS ASP ARG SEQRES 18 A 980 LYS PHE ARG VAL LYS ILE ARG GLY ILE ASP ILE PRO VAL SEQRES 19 A 980 LEU PRO ARG ASN THR ASP LEU THR VAL PHE VAL GLU ALA SEQRES 20 A 980 ASN ILE GLN HIS GLY GLN GLN VAL LEU CYS GLN ARG ARG SEQRES 21 A 980 THR SER PRO LYS PRO PHE THR GLU GLU VAL LEU TRP ASN SEQRES 22 A 980 VAL TRP LEU GLU PHE SER ILE LYS ILE LYS ASP LEU PRO SEQRES 23 A 980 LYS GLY ALA LEU LEU ASN LEU GLN ILE TYR CYS GLY LYS SEQRES 24 A 980 ALA PRO ALA LEU SER SER LYS ALA SER ALA GLU SER PRO SEQRES 25 A 980 SER SER GLU SER LYS GLY LYS VAL GLN LEU LEU TYR TYR SEQRES 26 A 980 VAL ASN LEU LEU LEU ILE ASP HIS ARG PHE LEU LEU ARG SEQRES 27 A 980 ARG GLY GLU TYR VAL LEU HIS MET TRP GLN ILE SER GLY SEQRES 28 A 980 LYS GLY GLU ASP GLN GLY SER PHE ASN ALA ASP LYS LEU SEQRES 29 A 980 THR SER ALA THR ASN PRO ASP LYS GLU ASN SER MET SER SEQRES 30 A 980 ILE SER ILE LEU LEU ASP ASN TYR CYS HIS PRO ILE ALA SEQRES 31 A 980 LEU PRO LYS HIS GLN PRO THR PRO ASP PRO GLU GLY ASP SEQRES 32 A 980 ARG VAL ARG ALA GLU MET PRO ASN GLN LEU ARG LYS GLN SEQRES 33 A 980 LEU GLU ALA ILE ILE ALA THR ASP PRO LEU ASN PRO LEU SEQRES 34 A 980 THR ALA GLU ASP LYS GLU LEU LEU TRP HIS PHE ARG TYR SEQRES 35 A 980 GLU SER LEU LYS HIS PRO LYS ALA TYR PRO LYS LEU PHE SEQRES 36 A 980 SER SER VAL LYS TRP GLY GLN GLN GLU ILE VAL ALA LYS SEQRES 37 A 980 THR TYR GLN LEU LEU ALA ARG ARG GLU VAL TRP ASP GLN SEQRES 38 A 980 SER ALA LEU ASP VAL GLY LEU THR MET GLN LEU LEU ASP SEQRES 39 A 980 CYS ASN PHE SER ASP GLU ASN VAL ARG ALA ILE ALA VAL SEQRES 40 A 980 GLN LYS LEU GLU SER LEU GLU ASP ASP ASP VAL LEU HIS SEQRES 41 A 980 TYR LEU LEU GLN LEU VAL GLN ALA VAL LYS PHE GLU PRO SEQRES 42 A 980 TYR HIS ASP SER ALA LEU ALA ARG PHE LEU LEU LYS ARG SEQRES 43 A 980 GLY LEU ARG ASN LYS ARG ILE GLY HIS PHE LEU PHE TRP SEQRES 44 A 980 PHE LEU ARG SER GLU ILE ALA GLN SER ARG HIS TYR GLN SEQRES 45 A 980 GLN ARG PHE ALA VAL ILE LEU GLU ALA TYR LEU ARG GLY SEQRES 46 A 980 CYS GLY THR ALA MET LEU HIS ASP PHE THR GLN GLN VAL SEQRES 47 A 980 GLN VAL ILE GLU MET LEU GLN LYS VAL THR LEU ASP ILE SEQRES 48 A 980 LYS SER LEU SER ALA GLU LYS TYR ASP VAL SER SER GLN SEQRES 49 A 980 VAL ILE SER GLN LEU LYS GLN LYS LEU GLU ASN LEU GLN SEQRES 50 A 980 ASN SER GLN LEU PRO GLU SER PHE ARG VAL PRO TYR ASP SEQRES 51 A 980 PRO GLY LEU LYS ALA GLY ALA LEU ALA ILE GLU LYS CYS SEQRES 52 A 980 LYS VAL MET ALA SER LYS LYS LYS PRO LEU TRP LEU GLU SEQRES 53 A 980 PHE LYS CYS ALA ASP PRO THR ALA LEU SER ASN GLU THR SEQRES 54 A 980 ILE GLY ILE ILE PHE LYS HIS GLY ASP ASP LEU ARG GLN SEQRES 55 A 980 ASP MET LEU ILE LEU GLN ILE LEU ARG ILE MET GLU SER SEQRES 56 A 980 ILE TRP GLU THR GLU SER LEU ASP LEU CYS LEU LEU PRO SEQRES 57 A 980 TYR GLY CYS ILE SER THR GLY ASP LYS ILE GLY MET ILE SEQRES 58 A 980 GLU ILE VAL LYS ASP ALA THR THR ILE ALA LYS ILE GLN SEQRES 59 A 980 GLN SER THR VAL GLY ASN THR GLY ALA PHE LYS ASP GLU SEQRES 60 A 980 VAL LEU ASN HIS TRP LEU LYS GLU LYS SER PRO THR GLU SEQRES 61 A 980 GLU LYS PHE GLN ALA ALA VAL GLU ARG PHE VAL TYR SER SEQRES 62 A 980 CYS ALA GLY TYR CYS VAL ALA THR PHE VAL LEU GLY ILE SEQRES 63 A 980 GLY ASP ARG HIS ASN ASP ASN ILE MET ILE THR GLU THR SEQRES 64 A 980 GLY ASN LEU PHE HIS ILE ASP PHE GLY HIS ILE ASN GLY SEQRES 65 A 980 ASN TYR LYS SER PHE LEU GLY ILE ASN LYS GLU ARG VAL SEQRES 66 A 980 PRO PHE VAL LEU THR PRO ASP PHE LEU PHE VAL MET GLY SEQRES 67 A 980 THR SER GLY LYS LYS THR SER PRO HIS PHE GLN LYS PHE SEQRES 68 A 980 GLN ASP ILE CYS VAL LYS ALA TYR LEU ALA LEU ARG HIS SEQRES 69 A 980 HIS THR ASN LEU LEU ILE ILE LEU PHE SER MET MET LEU SEQRES 70 A 980 MET THR GLY MET PRO GLN LEU THR SER LYS GLU ASP ILE SEQRES 71 A 980 GLU TYR ILE ARG ASP ALA LEU THR VAL GLY LYS ASN GLU SEQRES 72 A 980 GLU ASP ALA LYS LYS TYR PHE LEU ASP GLN ILE GLU VAL SEQRES 73 A 980 CYS ARG ASP LYS GLY TRP THR VAL GLN PHE ASN TRP PHE SEQRES 74 A 980 LEU HIS LEU VAL LEU GLY ILE LYS GLN GLY GLU LYS HIS SEQRES 75 A 980 SER ALA GLU PHE GLY LEU VAL PRO ARG GLY SER GLY HIS SEQRES 76 A 980 HIS HIS HIS HIS HIS HET 534 A2088 37 HETNAM 534 5-{3-[(4-{3-[4-(1-METHYLETHYL)PHENYL]PYRAZIN-2- HETNAM 2 534 YL}PIPERAZIN-1-YL)SULFONYL]PHENYL}PYRIMIDIN-2-AMINE FORMUL 2 534 C27 H29 N7 O2 S FORMUL 3 HOH *34(H2 O) HELIX 1 1 SER A 147 GLY A 159 1 13 HELIX 2 2 ASP A 171 ALA A 189 1 19 HELIX 3 3 ASP A 192 HIS A 199 1 8 HELIX 4 4 PRO A 208 LYS A 213 1 6 HELIX 5 5 THR A 240 THR A 250 1 11 HELIX 6 6 PRO A 286 ASN A 289 5 4 HELIX 7 7 PHE A 290 ASN A 299 1 10 HELIX 8 8 ASP A 312 GLU A 317 5 6 HELIX 9 9 LYS A 421 LEU A 423 5 3 HELIX 10 10 ASN A 498 THR A 503 5 6 HELIX 11 11 PRO A 548 THR A 561 1 14 HELIX 12 12 THR A 568 PHE A 578 1 11 HELIX 13 13 PHE A 578 LEU A 583 1 6 HELIX 14 14 LYS A 584 LYS A 587 5 4 HELIX 15 15 ALA A 588 SER A 594 1 7 HELIX 16 16 GLN A 600 ALA A 612 1 13 HELIX 17 17 ARG A 614 SER A 620 1 7 HELIX 18 18 ASP A 623 LEU A 630 1 8 HELIX 19 19 ASP A 637 GLU A 649 1 13 HELIX 20 20 GLU A 652 VAL A 667 1 16 HELIX 21 21 LYS A 668 GLU A 670 5 3 HELIX 22 22 SER A 675 ASN A 688 1 14 HELIX 23 23 ASN A 688 ALA A 704 1 17 HELIX 24 24 TYR A 709 ARG A 722 1 14 HELIX 25 25 GLY A 725 LEU A 752 1 28 HELIX 26 26 SER A 760 ASN A 773 1 14 HELIX 27 27 ALA A 797 CYS A 801 5 5 HELIX 28 28 ASP A 837 THR A 857 1 21 HELIX 29 29 ILE A 888 GLN A 893 1 6 HELIX 30 30 VAL A 906 SER A 915 1 10 HELIX 31 31 THR A 917 GLY A 943 1 27 HELIX 32 32 HIS A 948 ASP A 950 5 3 HELIX 33 33 THR A 988 GLY A 996 1 9 HELIX 34 34 SER A 1003 HIS A 1022 1 20 HELIX 35 35 HIS A 1023 MET A 1039 1 17 HELIX 36 36 LYS A 1045 LEU A 1055 1 11 HELIX 37 37 ASN A 1060 ASP A 1077 1 18 HELIX 38 38 TRP A 1080 TRP A 1086 1 7 SHEET 1 AA 5 SER A 230 VAL A 235 0 SHEET 2 AA 5 ILE A 220 HIS A 225 -1 O ILE A 220 N VAL A 235 SHEET 3 AA 5 HIS A 304 ASP A 308 1 O VAL A 305 N HIS A 225 SHEET 4 AA 5 VAL A 271 VAL A 274 -1 O VAL A 271 N ASP A 308 SHEET 5 AA 5 TYR A 280 LEU A 281 -1 O LEU A 281 N LEU A 272 SHEET 1 AB 4 GLU A 407 LYS A 419 0 SHEET 2 AB 4 LYS A 360 ASP A 369 -1 O PHE A 361 N PHE A 416 SHEET 3 AB 4 SER A 515 LEU A 519 -1 O SER A 515 N ASP A 369 SHEET 4 AB 4 GLU A 479 HIS A 483 -1 O TYR A 480 N ILE A 518 SHEET 1 AC 2 VAL A 393 ARG A 398 0 SHEET 2 AC 2 THR A 380 GLN A 388 -1 O ALA A 385 N ARG A 397 SHEET 1 AD 2 LYS A 402 PRO A 403 0 SHEET 2 AD 2 THR A 380 GLN A 388 -1 O VAL A 381 N LYS A 402 SHEET 1 AE 5 TRP A 485 GLN A 486 0 SHEET 2 AE 5 LEU A 460 LEU A 467 -1 O TYR A 463 N TRP A 485 SHEET 3 AE 5 LEU A 428 TYR A 434 -1 O LEU A 429 N LEU A 466 SHEET 4 AE 5 THR A 380 GLN A 388 -1 O PHE A 382 N TYR A 434 SHEET 5 AE 5 VAL A 393 ARG A 398 -1 N LEU A 394 O ILE A 387 SHEET 1 AF 5 TRP A 485 GLN A 486 0 SHEET 2 AF 5 LEU A 460 LEU A 467 -1 O TYR A 463 N TRP A 485 SHEET 3 AF 5 LEU A 428 TYR A 434 -1 O LEU A 429 N LEU A 466 SHEET 4 AF 5 THR A 380 GLN A 388 -1 O PHE A 382 N TYR A 434 SHEET 5 AF 5 LYS A 402 PRO A 403 -1 O LYS A 402 N VAL A 381 SHEET 1 AG 2 PHE A 783 ARG A 784 0 SHEET 2 AG 2 LYS A 792 ALA A 793 -1 O ALA A 793 N PHE A 783 SHEET 1 AH 5 LYS A 802 VAL A 803 0 SHEET 2 AH 5 LEU A 811 PHE A 815 -1 O TRP A 812 N LYS A 802 SHEET 3 AH 5 ILE A 828 HIS A 834 -1 O ILE A 828 N PHE A 815 SHEET 4 AH 5 ILE A 876 GLU A 880 -1 O GLY A 877 N LYS A 833 SHEET 5 AH 5 CYS A 869 GLY A 873 -1 O ILE A 870 N MET A 878 SHEET 1 AI 3 ALA A 885 THR A 887 0 SHEET 2 AI 3 ILE A 952 THR A 955 -1 O ILE A 954 N THR A 886 SHEET 3 AI 3 LEU A 960 HIS A 962 -1 O PHE A 961 N MET A 953 CISPEP 1 GLU A 145 GLU A 146 0 -13.82 CISPEP 2 TRP A 410 ASN A 411 0 -9.40 CISPEP 3 GLN A 775 ASN A 776 0 23.54 CISPEP 4 ALA A 901 PHE A 902 0 13.53 CISPEP 5 GLY A 966 HIS A 967 0 -27.15 CISPEP 6 HIS A 967 ILE A 968 0 -14.66 CISPEP 7 SER A 998 GLY A 999 0 8.07 CISPEP 8 ASP A 1077 LYS A 1078 0 9.15 SITE 1 AC1 15 MET A 804 TRP A 812 ILE A 831 LYS A 833 SITE 2 AC1 15 TYR A 867 ILE A 879 GLU A 880 ILE A 881 SITE 3 AC1 15 VAL A 882 THR A 887 ASP A 950 ASN A 951 SITE 4 AC1 15 MET A 953 ILE A 963 ASP A 964 CRYST1 143.424 68.531 106.263 90.00 95.26 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006972 0.000000 0.000642 0.00000 SCALE2 0.000000 0.014592 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009450 0.00000